NL-OMON51218已完成不适用
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19 - SAVID
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
Trial ended prematurely
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •18 years of age or older;
- •admitted to the COVID-19 cohort ward of the Franciscus Gasthuis &
- •Vlietland hospital for (suspicion of) SARS-CoV-2 infection;
- •written informed consent.
排除标准
- •undergoing experimental interventions for COVID-19;
研究者
相似试验
尚未招募
不适用
Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19NL-OMON20323Board of Directors Franciscus Gasthuis & Vlietland350
招募中
2 期
Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical applicatioAlzheimer's disease Other Dementia Mild cognitive impairment (MCI) Healthy volunteerJPRN-UMIN000023976ational Center for Geriatrics and Gerontology400
已完成
不适用
The Diagnostic and Prognostic Role of SAA in Intrathoracic SarcoidosisSarcoidosis, PulmonaryNCT05811962University Medical Centre Ljubljana135
Unknown
不适用
Evaluation of Serum Amyloid A in Early Diagnosis of Spontaneous Bacterial PeritonitisSpontaneous Bacterial PeritonitisNCT02759497Tanta University100
已完成
不适用
Prospective study on evaluation of amyloid accumulation in patients suspected of both cerebral amyloid angiopathy and isolated cortical venous thrombosis using Amyloid positron emission tomographycerebral amyloid angiopathy isolated cortical venous thrombosisJPRN-UMIN000037101Kohnan Hospital4